Search

Your search keyword '"Rasagiline -- Reports"' showing total 15 results
Start Over Descriptor "Rasagiline -- Reports"
15 results on '"Rasagiline -- Reports"'

1. Multiple System Atrophy Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma

Subjects
Innoviva Inc. -- Reports -- Growth, H. Lundbeck A/S -- Reports -- Growth, Biological products industry -- Industry forecasts, BCG vaccines -- Growth -- Reports, Atrophy -- Reports, BCG -- Growth -- Reports, Rasagiline -- Reports, Biotechnology industry -- Industry forecasts, Epidemiology -- Reports, Pharmaceutical industry -- Industry forecasts, Company growth, Business, Business, international
Abstract

M2 PRESSWIRE-November 20, 2024-: Multiple System Atrophy Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma (C)1994-2024 M2 [...]

Published
2024

2. Ruder Boskovic Institute Researchers Illuminate Research in Pharmaceuticals (Prominent Neuroprotective Potential of Indole-2-* * N* * -methylpropargylamine: High Affinity and Irreversible Inhibition Efficiency towards Monoamine Oxidase B ...)

Subjects
Rasagiline -- Reports, Monoamine oxidase -- Reports, Health
Abstract

2024 NOV 15 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New study results on pharmaceuticals have been published. According to news reporting out [...]

Published
2024

3. Parkinson's Disease Clinical Trials Analysis 2024: EMA, PDMA, FDA Approvals, Pipeline, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Rotigotine, LY03003, LY3884961, More

Subjects
AstraZeneca PLC -- Product development, Business -- Research, Rasagiline -- Reports, Diseases -- United Kingdom, Pramipexole -- Product development, Drug approval -- Reports, Clinical trials -- Reports, Pharmaceutical industry -- Product development, Exenatide -- Product development, Business, Business, international
Abstract

M2 PRESSWIRE-June 3, 2024-: Parkinson's Disease Clinical Trials Analysis 2024: EMA, PDMA, FDA Approvals, Pipeline, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Rotigotine, LY03003, LY3884961, More (C)1994-2024 [...]

Published
2024

5. Restkess Leg Syndrome Pipeline | Clinical Trials , Key Companies

Subjects
Business -- Research, Rasagiline -- Reports, Clinical trials -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-November 8, 2023-: Restkess Leg Syndrome Pipeline | Clinical Trials , Key Companies (C)1994-2023 M2 COMMUNICATIONS RDATE:07112023 Restless Leg Syndrome Pipeline Insight, 2023' report by DelveInsight outlays comprehensive insights [...]

Published
2023

6. Parkinson's Disease Clinical Trials and Therapies 2023: Latest breakthroughs, Treatment Market, Therapies, and Companies by DelveInsight | Abbvie, Roche, Kissei Pharmaceutical, Lundbeck, AstraZeneca

Subjects
AstraZeneca PLC -- Reports, Business -- Research, Rasagiline -- Reports, Pramipexole -- Reports, Pharmaceutical industry -- Reports, Exenatide -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-April 19, 2023-: Parkinson's Disease Clinical Trials and Therapies 2023: Latest breakthroughs, Treatment Market, Therapies, and Companies by DelveInsight | Abbvie, Roche, Kissei Pharmaceutical, Lundbeck, AstraZeneca (C)1994-2023 M2 COMMUNICATIONS [...]

Published
2023

7. Parkinson's Disease Drugs Pipeline 2023: Clinical Trials, Latest breakthroughs, Treatment Market, Therapies, and Companies by DelveInsight |Abbvie, Roche, Kissei Pharmaceutical, Lundbeck, AstraZeneca

Subjects
AstraZeneca PLC -- Reports, Business -- Research, Rasagiline -- Reports, Pramipexole -- Reports, Pharmaceutical industry -- Reports, Exenatide -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-April 10, 2023-: Parkinson's Disease Drugs Pipeline 2023: Clinical Trials, Latest breakthroughs, Treatment Market, Therapies, and Companies by DelveInsight |Abbvie, Roche, Kissei Pharmaceutical, Lundbeck, AstraZeneca (C)1994-2023 M2 COMMUNICATIONS RDATE:06042023 [...]

Published
2023

8. 140+ Active Companies working to Develop 150+ Pipeline Therapies for Parkinson's Disease Treatment

Subjects
Rasagiline -- Reports, Pramipexole -- Reports, Exenatide -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-March 24, 2023-: 140+ Active Companies working to Develop 150+ Pipeline Therapies for Parkinson's Disease Treatment (C)1994-2023 M2 COMMUNICATIONS RDATE:23032023 DelveInsight's, 'Parkinson's Disease Pipeline Insight 2023' report provides comprehensive [...]

Published
2023

9. Parkinson's Disease Pipeline Insights and Clinical Trials 2023 | DelveInsight

Subjects
Business -- Research, Rasagiline -- Reports, Pramipexole -- Reports, Clinical trials -- Reports, Exenatide -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-January 16, 2023-: Parkinson's Disease Pipeline Insights and Clinical Trials 2023 | DelveInsight (C)1994-2023 M2 COMMUNICATIONS RDATE:13012023 DelveInsight's, 'Parkinson's Disease Pipeline Insight, 2023,' report provides comprehensive insights about 140+ [...]

Published
2023

10. Parkinson's Disease Pipeline Analysis: 140+ Companies are Working to Improve the Treatment Space | DelveInsight

Subjects
Business -- Research, Rasagiline -- Reports, Pramipexole -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-November 8, 2022-: Parkinson's Disease Pipeline Analysis: 140+ Companies are Working to Improve the Treatment Space | DelveInsight (C)1994-2022 M2 COMMUNICATIONS RDATE:07112022 DelveInsight's, 'Parkinson's Disease Pipeline Insight, 2022,' report [...]

Published
2022

11. Reports on Parkinson's Disease Findings from University Institute of Pharmaceutical Sciences Provide New Insights (Polycaprolactone-based neurotherapeutic delivery of rasagiline targeting behavioral and biochemical deficits in Parkinson's ...)

Subjects
Physical fitness -- Reports, Monoamine oxidase -- Reports, Medical research -- Reports, Polycaprolactone -- Reports, Rasagiline -- Reports, Deglutition disorders, Obesity, Neurodegenerative diseases, Editors, Diseases, Health
Abstract

2020 MAR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Neurodegenerative Diseases and Conditions - Parkinson's Disease. [...]

Published
2020

12. Parkinson's Disease Pipeline Offers Promising New Options for Treatment | DelveInsight

Subjects
Rasagiline -- Reports, Pramipexole -- Reports, Exenatide -- Reports, Banking, finance and accounting industries, Business
Abstract

Los Angeles, USA, Jan 17, 2022 (GLOBE NEWSWIRE via COMTEX) -- Parkinson's Disease Pipeline Offers Promising New Options for Treatment | DelveInsight DelveInsight's 'Parkinson's Disease Pipeline Insight' report provides comprehensive [...]

Published
2022

13. Findings in the Area of Parkinson's Disease Reported from University Institute of Pharmaceutical Sciences (Polycaprolactone-based neurotherapeutic delivery of rasagiline targeting behavioral and biochemical deficits in Parkinson's disease)

Subjects
Physical fitness -- Reports, Monoamine oxidase -- Reports, Medical research -- Reports, Polycaprolactone -- Reports, Rasagiline -- Reports, Deglutition disorders, Obesity, Neurodegenerative diseases, Editors, Health
Abstract

2019 NOV 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Neurodegenerative Diseases and Conditions - Parkinson's Disease are discussed [...]

Published
2019

14. Monoamine Oxidase Inhibitors Pipeline Insight Report 2021 - ResearchAndMarkets.com

Subjects
Methylene blue -- Reports, Homeopathy -- Materia medica and therapeutics, Rasagiline -- Reports, Therapeutics -- Reports, Oxidases -- Reports, Business, Business, international
Abstract

DUBLIN -- The 'Monoamine Oxidase Inhibitors - Pipeline Insight, 2021' drug pipelines has been added to ResearchAndMarkets.com's offering. This 'Monoamine Oxidase Inhibitors - Pipeline Insight, 2021' report provides comprehensive insights [...]

Published
2021

15. Monoamine Oxidase Inhibitors Pipeline Insight Report 2021

Subjects
Methylene blue -- Reports, Homeopathy -- Materia medica and therapeutics, Rasagiline -- Reports, Therapeutics -- Reports, Oxidases -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-July 5, 2021-: Monoamine Oxidase Inhibitors Pipeline Insight Report 2021 (C)1994-2021 M2 COMMUNICATIONS RDATE:05072021 The 'Monoamine Oxidase Inhibitors - Pipeline Insight, 2021' drug pipelines has been added to ResearchAndMarkets.com's [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results